GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we treat diabetes mellitus . These injectable drugs function to stimulating the body’s own GLP-1 substance , https://agnesdpnw890128.bloggactif.com/43446437/glp-1-a-significant-breakthrough-in-diabetes-care